Skip to main content

Closed

SGMT: Sagimet Biosciences Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-47.5%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio20.34×

Sagimet Biosciences Inc.

SGMTNASDAQ·USD·Closed

Sagimet Biosciences Inc.

SGMTNASDAQ·USD·Closed

$7.11

−2.74%

$7.11

−$0.20 (2.74%)

52W Range

47thpctl

Volume

0.57×avg

Mkt Cap

231.66MUSD

P/E

-5.3TTM

Div Yield

–ann

52W Range

47thpctl

Volume

0.57×avg

Market Cap

231.66MUSD

P/E Ratio

-5.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings